Notice Type
Secondary Legislation
Notice Title

Specification of COVID-19 Vaccines for the Purpose of the Maritime Border Order

Pursuant to section 5(3)(b) of the COVID-19 Public Health Response Act 2020, I, Dr Ashley Bloomfield, Director-General of Health, declare that the doses of each COVID-19 vaccine or combination of COVID-19 vaccines specified in this notice are required for a person to be “vaccinated” for the purpose of clause 12 of the COVID-19 Public Health Response (Maritime Border) Order (No 2) 2020 (“Order”). A combination of vaccine doses will meet the definition where this is the accepted schedule in the place of vaccination.

For the purposes of clause 12 of the Order, vaccinated means being vaccinated against COVID-19 with at least one of the following complete vaccination courses (meaning the combination of COVID-19 vaccine and number of doses in each line):

 

Manufacturer
(Marketing Authorisation Holder)

Vaccine name

Other names (including research name)

Dose(s) required

1.

Bharat Biotech

Covaxin

BBV152

2

2.

Janssen

(Johnson & Johnson)

Janssen

Ad26.COV2.S1

JNJ-78436735

1

3.

Moderna

Spikevax

mRNA-1273

2

4.

Novavax

Nuvaxovid

NVX-CoV2373

2

5.

Oxford/AstraZeneca

Vaxzevria

AZD1222

ChAdOx1 nCoV-19

2

6.

Pfizer/BioNTech

Comirnaty

BNT162b2

Tozinameran

2

7.

Serum Institute of India

(AstraZeneca)

Covishield

AZD1222

2

8.

Serum Institute of India

(Novavax)

Covovax

 

2

9.

Sinopharm (Beijing)

BBIBP-CorV

Covilo

Also LIBP, CCIBP, CDIBP, CNBG, BIBP

2

10.

Sinovac

CoronaVac

PiCoVacc

2

11.

CanSinoBIO

Convidecia

PakVac

Ad5-nCoV

1

12.

Anhui Zhifei Longcom

Zifivax

ZF2001

ZF-UZ-VAC-2001 RBD-Dimer

2

13.

Bagheiat-allah University of Medical Sciences

Noora

 

3

14.

Biological E Limited

Corbevax

BECOV2D

2

15.

Center for Genetic Engineering and Biotechnology (CIGB)

Abdala

 

CIGB-66

2

16.

Chumakov Centre

KoviVac

 

2

17.

Federal Budgetary Research Institution State Research Center of Virology and Biotechnology (FBRI)

EpiVacCorona

VECTOR

 

2

18.

Federal Budgetary Research Institution State Research Center of Virology and Biotechnology (FBRI)

EpiVacCorona-N

Aurora-CoV

 

2

19.

Gamaleya Research Institute of Epidemiology and Microbiology

Sputnik Light

 

1

20.

Gamaleya Research Institute of Epidemiology and Microbiology

Sputnik V

Gam-COVID-Vac

2

21.

Gamaleya Research Institute of Epidemiology and Microbiology

Gam-COVID-Vac

Sputnik

rAd5

2 (Nasal spray)

22.

Health Institutes of Turkey

Turkovac

ERUCOV-VAC

2

23.

Instituto Finlay de Vacunas Cuba

Soberana 02

FINLAY-FR-2

Pasteurcovac

2

24.

Instituto Finlay de Vacunas Cuba

Soberana Plus

FINLAY-FR-1A

Only as a 3rd dose after 2 doses of Soberana 02

25.

Kazakhstan Research Institute for Biological Safety Problems

QazVac

QazCovid-in

RIBSPm

2

26.

Medicago Inc.

COVIFENZ

coVLP

2

27.

Medigen Vaccine Biologics Corporation

MVC COVID-19 vaccine

MVC-COV1901

2

28.

Shenzhen Kangtai Biological Products, Minhai Biotechnology Co (Beijing)

KCONVAC

KconecaVac

Minhai COVID-19 vaccine

BIOKANGTAI

2

29.

National Vaccine and Serum Institute (China)

Recombinant SARS-CoV-2 Vaccine (CHO Cell)

NVSI-06-08

3

30.

Organization of Defensive Innovation and Research (Iran)

FAKHRAVAC

MIVAC

2

31.

Razi Vaccine and Serum Research Institute (Iran)

Razi Cov Pars

 

3

32.

Shifa Pharmed Industrial Co (Iran)

COVIran Barekat

BIV1-CovIran

COVIran Barakat

COVIran Barkat

2

33.

Sinopharm (Wuhan)

WIBP-CorV

Inactivated (Vero Cells)

2

34.

Takeda (Japan)/ Novavax

TAK-019

(Novavax formulation)

2

35.

Takeda

(Japan)/ Moderna

TAK-919

(Moderna formulation)

2

36.

Valneva SE/ Dynavax Technologies

VLA2001

VLA2101

2

37.

Vaxine/CinnaGen Co.

(Australia)

SpikoGen

COVAX-19

2

38.

Zydus Cadila (Cadila Healthcare)

ZyCoV-D

 

3


This notice comes into effect at 11.59pm on 31 July 2022.

Dated at Wellington this 26th day of July 2022.

Dr ASHLEY BLOOMFIELD, Te Tumu Whakarae mō te Hauora, Director-General of Health.